JIJUN LIU MD NPI 1043474042

NPI Details

Jijun Liu, MD is a hematology and oncology internal medicine in Peoria, IL with 28 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jijun Liu, MD NPI is 1043474042. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

8940 N. WOOD SAGE ROAD
PEORIA, IL
ZIP 61615
Phone: (309) 243-3000
Fax: (309) 243-3215

The NPI 1043474042 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Ferritin (blood protein) level (HCPCS:82728)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Folic acid level, serum (HCPCS:82746)
• Magnesium level (HCPCS:83735)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Protein measurement, serum (HCPCS:84165)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Ct scan of chest with contrast (HCPCS:71260)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Uric acid level, blood (HCPCS:84550)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Unclassified drugs (HCPCS:J3490)
• Collection of blood sample from implanted device (HCPCS:36591)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Red blood count, automated test (HCPCS:85045)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Smoking and tobacco use intensive counseling, 4-10 minutes (HCPCS:99406)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Vitamin d-3 level (HCPCS:82306)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Electrophoresis, laboratory testing technique (HCPCS:82664)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Phosphate level (HCPCS:84100)
• Ct scan of chest without contrast (HCPCS:71250)
• X-ray of chest, 2 views (HCPCS:71046)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)

The enumeration date for this NPI number is 7/18/2008 and was last updated on 4/9/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: